Xpert MTB/RIF was implemented in 2016 as the initial diagnostic test for extrapulmonary, pediatric, and human immunodeficiency virus–associated tuberculosis (TB) and as an add-on test for sputum microscopy–negative patients under Revised National TB Control Programme, Puducherry, India. The authors intended to study the change in TB case notification rates (CNRs) after 2015 and explore the enablers and barriers for implementation of Xpert.
Materials and Methods
Sequential mixed-methods study, quantitative phase followed by a descriptive qualitative phase (key informant interviews with healthcare providers in the program).
This research was supported by the UK Department for International Development’s Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)
Newtonraj A, Venables E, Selvaraj K, Kundu D, Purty A, Manikandan M, Shewade H. Xpert negative means no TB: A mixed-methods study into early implementation of Xpert in Puducherry, India.
Journal of Family Medicine and Primary Care. 2019;8(4):1379.
Xpert negative means no TB: A mixed-methods study into early implementation of Xpert in Puducherry, India